NeuroDx Unveils MANAS-1, India’s Native AI Brain Model at India AI Summit

Deeptech startup NeuroDx, one of the 12 startups selected under the IndiaAI Mission, unveiled MANAS-1, a 400-million-parameter brain foundation model designed to decode human brain electrical activity and support early diagnosis of neurological disorders. 

The launch took place at the India AI Impact Summit. 

The company said MANAS-1 is built on Indian clinical data and research, positioning it as a fully native AI model tailored to domestic healthcare realities. The system is designed as a decision-support tool for clinicians and researchers, with a focus on scalable and ethical brain health insights.

NeuroDx aims to address a growing global burden of neurological and psychiatric conditions, which affect over 600 million people worldwide. The model seeks to improve the speed and accuracy of diagnostics by analysing electroencephalogram signals and other neurological data using transformer-based architectures.

The company claims that Manas-1 has achieved accuracy of over 95% for identifying biomarkers in Epilepsy and other mental health disorders.

The startup, founded by Kailash Sati and Siddharth Panwar, experts from AIIMS New Delhi, Stanford University, IIT Delhi and IIT Kanpur, said it is developing affordable, non-invasive diagnostic tools powered by AI. It plans to integrate human and AI collaboration in neuroscience to enhance clinical confidence and research outcomes.

In parallel, the company is working on a larger 20 billion parameter foundation model focused on EEG signal analysis. This next phase aims to enable early screening of neurological disorders and support future brain-computer interface applications.

With MANAS-1, NeuroDx joins a growing cohort of Indian startups building sovereign AI systems in healthcare, as the government pushes for domestic AI capabilities across strategic sectors.